Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Withdrawn × Disease Progression × Clear all

Phase

Phase 1/2 3 Phase 2 2 Phase NA 1

Status

Unknown 5 Completed 4 Recruiting 3 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 105 Neoplasms 65 Prostatic Neoplasms 59 Colorectal Neoplasms 28 Lung Neoplasms 27 Carcinoma, Non-Small-Cell Lung 27 Head and Neck Neoplasms 26 Pancreatic Neoplasms 24 Carcinoma, Hepatocellular 21 Brain Neoplasms 21 Colonic Neoplasms 19 Motor Activity 17 Pain 14 Carcinoma, Renal Cell 14 Rectal Neoplasms 13 Fatigue 13 Urinary Bladder Neoplasms 12 Ovarian Neoplasms 12 Neoplasm Metastasis 12 Liver Neoplasms 11 Hematologic Neoplasms 11 Lymphoma, Follicular 10 Anxiety Disorders 10 Lymphoma 9 Leukemia 9 Glioma 9 Glioblastoma 9 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Sarcoma 8

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01210131 2013-08-27

HX4 in SCLC

Maastricht Radiation Oncology

Phase NA Withdrawn

Disease Progression, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡